The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Predictive models of recurrence from transcriptomic signatures of the tumor microenvironment and cell cycle in stage III colon cancer from PETACC-8 and IDEA France trials.
 
Claire Gallois
Consulting or Advisory Role - SERVIER
Travel, Accommodations, Expenses - Amgen
 
Marine SROUSSI
No Relationships to Disclose
 
Thierry Andre
Honoraria - AMGEN; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Serono; Merck Serono; Pierre Fabre; Roche/Genentech; Sanofi; Seagen; SERVIER; Ventana Medical Systems
Consulting or Advisory Role - Amgen; Aptitude Health; Astellas Pharma; AstraZeneca/MedImmune; Bristol-Myers Squibb; GamaMabs Pharma; Gilead Sciences; GlaxoSmithKline; Gritstone Bio; Kaleido Biosciences; MSD Oncology; Nordic Bioscience; Pierre Fabre; Seagen; SERVIER; Tesaro; Transgene
Travel, Accommodations, Expenses - MSD Oncology; MSD Oncology
(OPTIONAL) Uncompensated Relationships - Adjuvant Colon Cancer End Points (ACCENT) Collaborative Group; ARCAD Foundation; ARCAD Foundation; Gercor
 
Sophie Mouillet-Richard
No Relationships to Disclose
 
Natacha Agueeff
No Relationships to Disclose
 
Dewi Vernerey
No Relationships to Disclose
 
Christophe Louvet
Consulting or Advisory Role - Amgen; Merck; MSD Oncology; Roche
Travel, Accommodations, Expenses - Merck; Roche
 
Jean-Baptiste Bachet
Honoraria - Amgen; AstraZeneca; Bayer; Merck Serono; MSD Oncology; Pierre Fabre; Roche; Sanofi; SERVIER; Viatris
Consulting or Advisory Role - AC BioScience; Acobiom; Amgen; AstraZeneca; Bayer; BMS; GlaxoSmithKline; Incyte; Merck Serono; MSD; Pierre Fabre; Servier
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Servier
 
Louis-Marie Dourthe
No Relationships to Disclose
 
Thibault Mazard
No Relationships to Disclose
 
Marine Jary
Consulting or Advisory Role - Incyte
Speakers' Bureau - Pierre Fabre; SERVIER
Research Funding - Bayer (Inst)
Travel, Accommodations, Expenses - Bayer; Pierre Fabre; Roche; SERVIER
 
Christelle De La Fouchardiere
Honoraria - Merck Serono; Merck Serono; Roche; Roche
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Eisai; Incyte; Ipsen; Ipsen; Lilly; MSD Oncology; Pierre Fabre; Roche; SERVIER
Research Funding - Pierre Fabre (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Pierre Fabre; Roche; SERVIER; SERVIER
Other Relationship - Amgen; Incyte; MSD Oncology
 
Cedric Lecaille
Travel, Accommodations, Expenses - Amgen; Olympus; SERVIER
 
Josep Tabernero
Stock and Other Ownership Interests - Oniria Therapeutics
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; Boehringer Ingelheim; Cardiff Oncology; Chugai Pharma; Daiichi Sankyo; F. Hoffmann LaRoche; Genentech; HalioDx; Hutchison MediPharma; Ikena Oncology; Inspirna; IQvia; Lilly; Menarini; Merck Serono; Merus; Mirati Therapeutics; MSD; Neophore; Novartis; Ona Therapeutics; Orion Biotechnology; Peptomyc; Pfizer; Pierre Fabre; Samsung Bioepis; Sanofi; Scandion Oncology; Scorpion Therapeutics; Seagen; Servier; Sotio; Taiho Pharmaceutical; Tessa Therapeutics; TheraMyc; Tolremo
Other Relationship - Imedex/HMP; Medscape; MJH Life Sciences; Peerview; Physicans' Education Resource
 
Jean-Luc Van Laethem
No Relationships to Disclose
 
Come Lepage
Honoraria - Amgen; Ipsen; Pierre Fabre
Consulting or Advisory Role - Advanced Accelerator Applications; Novartis
Travel, Accommodations, Expenses - Ipsen; Merck Serono; Novartis
 
Jean Francois Emile
No Relationships to Disclose
 
Aurélien de Reynies
No Relationships to Disclose
 
Julien Taieb
Consulting or Advisory Role - Amgen; AstraZeneca; BMS; Merck KGaA; MSD; Novartis; Pierre Fabre; Roche; SERVIER
Speakers' Bureau - Amgen; Merck; MSD; Pierre Fabre; SERVIER
 
Pierre Laurent Puig
Stock and Other Ownership Interests - Methys
Honoraria - Amgen; AstraZeneca; BIOCARTIS; Merck; MSD Oncology; Roche; Sanofi
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Merck
Patents, Royalties, Other Intellectual Property - Inventor of mir31-3p licence to integragen
Travel, Accommodations, Expenses - Merck; Roche